Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

Investigational New Drugs, 0167-6997

Tidsskrift

  1. 2020
  2. Udgivet

    Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma

    Even, C., Lassen, U., Merchan, J., Le Tourneau, C., Soria, J-C., Ferte, C., Ricci, F., Diener, J. T., Yuen, E., Smith, C., Oakley, G. J., Benhadji, K. A. & Massard, C., apr. 2020, I : Investigational New Drugs. 38, 2, s. 402-409 8 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. 2018
  4. Udgivet

    Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer

    Schneeweiss, A., Park-Simon, T-W., Albanell, J., Lassen, U., Cortés, J., Dieras, V., May, M., Schindler, C., Marmé, F., Cejalvo, J. M., Martinez-Garcia, M., Gonzalez, I., Lopez-Martin, J., Welt, A., Levy, C., Joly, F., Michielin, F., Jacob, W., Adessi, C., Moisan, A., Meneses-Lorente, G., Racek, T., James, I., Ceppi, M., Hasmann, M., Weisser, M. & Cervantes, A., okt. 2018, I : Investigational New Drugs. 36, 5, s. 848-859 12 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Udgivet

    Combined treatment with pemetrexed and vinflunine in patients with metastatic urothelial cell carcinoma after prior platinum-containing chemotherapy - results of an exploratory phase I study

    Pappot, H., von der Maase, H., Ullén, A., Agerbæk, M. & NUCOG - Nordic Urothelial Cancer Oncology Group (NUCOG), 2018, I : Investigational New Drugs. 36, 4, s. 615-618

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

ID: 59489